Efficacy and safety of HD-tDCS and respiratory rehabilitation for critically ill patients with COVID-19 The HD-RECOVERY randomized clinical trial
Randomized Controlled Trial
[키워드] 1:1
acute respiratory distress syndrome
addition
Adverse
adverse effect
attenuate
Brain
clinical response
conducted
coronavirus disease
corticospinal
COVID-19
Critically ill patient
current
defined
delirium
Direct
Direct Current
distress
dysfunction
Efficacy
Efficacy and safety
evaluate
event
fatigue
feasible
groups
High-definition transcranial direct current stimulation
hospital
impairment
increase in
intensive care
Intervention
investigated
mechanical ventilation
moderate
Mortality
no significant difference
Noninvasive brain stimulation
organ dysfunction
Organ failure
pathway
patients
patients with COVID-19
patients with moderate
positive
Primary outcome
Randomized
randomized clinical trial
rehabilitation
respiratory
respiratory rehabilitation
Safe
secondary outcome
severe ARDS
severe hypoxemia
statistically significant
Stimulation
therapy
Trial
unit discharge
ventilator-free day
with COVID-19
[DOI] 10.1016/j.brs.2022.05.006 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1016/j.brs.2022.05.006 PMC 바로가기 [Article Type] Randomized Controlled Trial